Unusual retention behavior of some cationic-type aldoximes used as AChE reactivators under ion-pairing liquid chromatographic mechanism

Analytical Letters

Volumn 43, Issue 7, 2010, Pages 1267-1276

  Voicu, Victor ^a   Medvedovici, Andrei ^b   Radulescu, Medeea ^b   Iorgulescu, Emilia Elena ^b   David, Victor ^b  

^a CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b UNIVERSITY OF BUCHAREST   (Romania)

Author keywords

AChE reactivators; Cationic type aldoximes; Ion pair mechanism; Retention behavior; Tautomerism

Indexed keywords

EID: 77952661810     PISSN: 00032719     EISSN: 1532236X     Source Type: Journal    
DOI: 10.1080/00032710903518682     Document Type: Article

References (22)

1. Bartha, A., and J. Stahlberg. 1994. Electrostatic retention model of reversed-phase ion-pair chromatography. J. Chromatogr. A 668: 255-284.
2. Castro, A. T., and J. D. Figueroa-Villar. 2002. Molecular structure, conformational analysis and charge distribution of pralidoxime: Ab Initio and DFT studies. Internat. J. Quant. Chem. 89: 135-146.
3. David, V., A. Medvedovici, and F. Albu. 2005. Retention behavior of metformin and related impurities in ion-pairing liquid chromatography. J. Liq. Chromatogr. Rel. Technol. 28: 81-95.
4. David, V., and A. Medvedovici. 2007. Structure - retention correlation in liquid chromatography for pharmaceutical applications. J. Liq. Chromatogr. Rel. Technol. 30: 761-789.
5. Fischer, H., R. Gottschlich, and A. Seelig. 1998. Blood-Brain Barrier Permeation: Molecular Parameters Governing Passive Diffusion. J. Membrane Biol. 165: 201-211.
6. Flanagan, R. J., and A. L. Jones. 2001. Antidotes, Chapter 7: 245-268. London, UK: Taylor and Francis.
7. Galaon, T., A. Medvedovici, and V. David. 2008. Hydrophobicity parameter (logKow) estimation for some phenolic compounds of pharmaceutical interest from retention studies with mobile phase composition in RP-LC. Sep. Sci. Technol. 43: 147-163.
8. Grasshoff, C., H. Thiermann, T. Gillesen, T. Zilket, and L. Szinicz. 2001. Internal standard high-performance liquid chromatography method for the determination of obidoxime in urine of organophosphate-poisoned patients. J. Chromatogr. B: Biomed. Sci. Appl. 753: 203-208.
9. Houze, P., S. W. Borron, F. Scherninski, B. Bousquet, B. Gourmel, and F. Baud. 2005. Measurement of serum pralidoxime methylsulfate (Contrathion) by high-performance liquid chromatography with electrochemical detection. J. Chromatogr. B 814: 149-154.
10. Iyer, M., R. Mishra, Y. Han, and A. J. Hopfinger. 2002. Predicting blood-brain barrier partitioning of organic molecules using membrane-interaction QSAR analysis. Pharm. Res. 19: 1611-1621.
11. Kalasz, H., M. Y. Hasan, R. Sheen, K. Kuca, G. Petroianu, K. Ludanyi, A. Gergely, and K. Tekes. 2006. HPLC analysis of K-48 concentration in plasma. Anal. Bioanal. Chem. 385: 1062-1067.
12. Kassa, J. 2002. Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents. J. Toxicol. Clin. Toxicol. 40: 803-816.
13. Musilek, K., J. Jampilek, J. Dohnal, D. Jun, F. Gunn-Moore, M. Dolezal, and K. Kuca. 2008. RP-HPLC determination of the lipophilicity of bispyridinium reactivators of cetylcholines- terase bearing a but-2-ene connecting linker. Anal. Bional. Chem. 391: 367-372.
14. Musilek, K., K. Kuca, and D. Jun. 2007. Evaluation of potency (pralidoxime, trimedoxime, HI-6, methoxime, obidoxime) to in vitro reactivate acetylcholinesterase inhibated by pesticides (chlorpyrifos and methylchlorpyrifos) and nerve agent (Russian VX). Acta Medica 50: 203-206.
15. Nichthauser, J., and P. Stepnowski. 2009. Retention mechanism of selected ionic liquids on a pentafluorophenylpropyl polar phase: Investigation using RP-HPLC. J. Chromatogr. Sci. 47: 247-253.
16. Paddle, B. M., and M. H. Dowling. 1993. Simple high-performance liquid chromatographic method for assessing the deterioration of atropine-oxime mixtures employed as antidotes in the treatment of nerve agent poisoning. J. Chromatogr. 648: 373-380.
17. Pohjola, J., and M. Harpf. 1994. Determination of atropine and obidoxime in automatic injection devices used as antidotes against nerve agent intoxication. J. Chromatogr. A 686: 350-354.
18. Poole, S. K., and C. F. Poole. 2003. Separation methods for estimating octanol-water partition coefficients. J. Chromatogr. B 797: 3-19.
19. Shiloff, J. D., and J. G. Clement. 1987. Comparison of serum concentrations of the acetylcho- linesterase oxime reactivators HI-6, obidoxime, and PAM to efficacy against sarin (isopropyl methylphosphonofluoridate) poisoning in rats. Toxicol. Appl. Pharmacol. 89: 278-280.
20. Silva, G. R., I. Borges Jr., and J. D. Figueroa-Villar. 2005. DFT conformational studies of the HI-6 molecule. Internat. J. Quant. Chem. 105: 260-269.
21. Tekes, K., M. Y. Hasan, R. Sheen, K. Kuca, G. Petroianu, K. Ludanuy, and H. Kalasz. 2006. High-performance liquid chromatography determination of the plasma concentration of K-27, a novel oxime-type cholinesterase reactivator. J. Chromatogr. A 1122: 84-87.
22. Valkó, K.2004.Application of high-pressure liquid chromatography based measurements of lipophilicity to model biological distribution. J. Chromatogr. A 1037: 299-310.